IMVT
Immunovant, Inc. · Healthcare
CEO Peter Salzmann sold $425K of Immunovant, Inc.
Sold$424,811
$25.45Price
16,692Shares
−2%Stake
What IMVT did after the filing
- The stock from Fri, Nov 22 close, $26.87
- −12.1%
- S&P 500, same days
- −0.7%
Measured over 30 trading days, to the Jan 8 close.
Traded Wed, Nov 20. Filed Fri, Nov 22, 11:08 AM ET, during the session. Returns use the Nov 22 close and the Jan 8 close. Not investment advice.